Post Profile

What Does It Cost to Create a Cancer Drug? Less Than You’d Think

A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
read more


Related Posts

Drug war, Islamists 'rising' risks for Philippines: Moody's

News : The Lookout

President Rodrigo Duterte's deadly drug war and armed Islamist rebellion pose "rising" risks to the Philippine economy, though it should continue to grow robustly in the short term, Moody's Investors Service said. Duterte is battlin...

Myriad Genetics, Inc. (MYGN): Big Pharma’s Intellectual Property Blues

Business & Finance / Investing : Insider Monkey

It’s not easy being a biotech company. Every year, the biotech industry pours billions of dollars in research and development costs towards creating cutting edge drugs that treat major diseases. If these drugs are approved, then the...

A small Boston biotech is at the heart of a groundbreaking approach to tackling cancer (AGIO)

Business & Finance : Business Insider: Clusterstock

Agios Pharmaceuticals, a company that got its start less than a decade ago, already has one drug in front of the FDA. The company makes drugs that essentially try to repair cancer cells so they can grow old. If the drug's approved, ...

See jerkface bacteria hiding in tumors and gobbling chemotherapy drugs

Technology / Technology Industry News : Ars Technica

They make cancers drug-resistant, but a dose of antibiotics may help, study suggests.

23andMe is getting serious about drug development — and it could signal a fresh approach to finding new medicines

Technology / Technology Industry News : Silicon Alley Insider

23andMe, a company known for its consumer genetics test, is also looking to develop new drugs. The company raised $250 million on Tuesday, and the funding will in part go toward drug development. While drug development and consumer ...


Copyright © 2016 Regator, LLC